Alembic Pharma's JV Aleor Dermaceuticals gets American regulator nod for Testosterone Gel
Aleor Dermaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its ANDA for its abbreviated new drug application (ANDA) for Testosterone Gel, 1.62%, Alembic Pharmaceuticals said in a regulatory filing.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: AndroGel | Biotechnology | Dermatology | Food and Drug Administration (FDA) | New Drug Applications | Pharmaceuticals